Systematic review of validation studies of the use of administrative data to identify serious infections

Arthritis Care and Research

Volumn 65, Issue 8, 2013, Pages 1343-1357

  Barber, Claire ^a,c   Lacaille, Diane ^b   Fortin, Paul R ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ALGORITHM; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BACTERIAL INFECTION; CANDIDIASIS; CENTRAL NERVOUS SYSTEM INFECTION; COCCIDIOIDOMYCOSIS; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; HUMAN; ICD-10; ICD-9-CM; INFECTIOUS COMPLICATION; LUNG TUBERCULOSIS; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PNEUMONIA; PREDICTIVE VALUE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEPSIS; SYSTEMATIC REVIEW; VALIDATION STUDY;

EID: 84881364133     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21959     Document Type: Article

References (29)

1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE,. Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002; 46: 2294-300.
2. Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM,. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum 2008; 59: 1074-81.
3. Barber C, Gold WL, Fortin PR,. Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 2011; 23: 358-65.
4. Bernatsky S, Lix L, O'Donnell S, Lacaille D, and the CANRAD Network. Consensus statements for the use of administrative health data in rheumatic disease research and surveillance. J Rheumatol 2013; 40: 66-73.
5. Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A,. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011; 64: 821-9.
6. Curtis JR, Martin C, Saag KG, Patkar NM, Kramer J, Shatin D, et al. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs. Arthritis Rheum 2007; 57: 343-6.
7. Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists. Arthritis Rheum 2007; 56: 1125-33.
8. Aronsky D, Haug PJ, Lagor C, Dean NC,. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual 2005; 20: 319-28.
9. Whittle J, Fine MJ, Joyce DZ, Lave JR, Young WW, Hough LJ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual 1997; 12: 187-93.
10. Gedeborg R, Furebring M, Michaelsson K,. Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol 2007; 60: 155-62.
11. Grijalva CG, Chung CP, Stein CM, Gideon PS, Dyer SM, Mitchel EF Jr, et al. Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2008; 17: 890-5.
12. Landers T, Apte M, Hyman S, Furuya Y, Glied S, Larson E,. A comparison of methods to detect urinary tract infections using electronic data. Jt Comm J Qual Patient Saf 2010; 36: 411-7.
13. Patkar NM, Curtis JR, Teng GG, Allison JJ, Saag M, Martin C, et al. Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. J Clin Epidemiol 2009; 62: 321-7.
14. Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH,. Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol 2007; 60: 397-409.
15. Madsen KM, Schonheyder HC, Kristensen B, Nielsen GL, Sorensen HT,. Can hospital discharge diagnosis be used for surveillance of bacteremia? A data quality study of a Danish hospital discharge registry. Infect Control Hosp Epidemiol 1998; 19: 175-80.
16. Ollendorf DA, Fendrick AM, Massey K, Williams GR, Oster G,. Is sepsis accurately coded on hospital bills? Value Health 2002; 5: 79-81.
17. Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM Jr, Breiman RF,. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149: 282-9.
18. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-55.
19. Marrie TJ, Durant H, Sealy E,. Pneumonia: the quality of medical records data. Med Care 1987; 25: 20-4.
20. Meropol SB, Metlay JP,. Accuracy of pneumonia hospital admissions in a primary care electronic medical record database. Pharmacoepidemiol Drug Saf 2012; 21: 659-65.
21. Skull SA, Andrews RM, Byrnes GB, Campbell DA, Nolan TM, Brown GV, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or = 65 years. Epidemiol Infect 2008; 136: 232-40.
22. Van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG,. International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007; 60: 834-8.
23. Yu O, Nelson JC, Bounds L, Jackson LA,. Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data. Epidemiol Infect 2011; 139: 1296-306.
24. Calderwood MS, Platt R, Hou X, Malenfant J, Haney G, Kruskal B, et al. Real-time surveillance for tuberculosis using electronic health record data from an ambulatory practice in eastern Massachusetts. Public Health Rep 2010; 125: 843-50.
25. Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG,. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2012; 21: 666-9.
26. Trepka MJ, Beyer TO, Proctor ME, Davis JP,. An evaluation of the completeness of tuberculosis case reporting using hospital billing and laboratory data; Wisconsin, 1995. Ann Epidemiol 1999; 9: 419-23.
27. Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011; 20: 229-35.
28. Yokoe DS, Subramanyan GS, Nardell E, Sharnprapai S, McCray E, Platt R,. Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerg Infect Dis 1999; 5: 779-87.
29. Yokoe DS, Coon SW, Dokholyan R, Iannuzzi MC, Jones TF, Meredith S, et al. Pharmacy data for tuberculosis surveillance and assessment of patient management. Emerg Infect Dis 2004; 10: 1426-31.